Protein Instability and Immunogenicity: Roadblocks to Clinical Application of Injectable Protein Delivery Systems for Sustained Release-Reference-Cited by-同舟云学术

Protein Instability and Immunogenicity: Roadblocks to Clinical Application of Injectable Protein Delivery Systems for Sustained Release

Published:2012-03 Issue:3 Volume:101 Page:946-954
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Jiskoot Wim,Randolph Theodore W.,Volkin David B.,Russell Middaugh C.,Schöneich Christian,Winter Gerhard,Friess Wolfgang,Crommelin Daan J.A.,Carpenter John F.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference37 articles.

1. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles;Wischke;Int J Pharm,2008

2. The common technical document for the registration of pharmaceuticals for human use: Module 3: Quality;ICH Harmonised Tripartite Guideline M4Q(R1),2002

3. Effects of protein aggregates: An immunologic perspective;Rosenberg;AAPS J,2006

4. Overlooking subvisible particles in therapeutic protein products: Gaps that may compromise product quality;Carpenter;J Pharm Sci,2009

5. Strategies for the assessment of protein aggregates in pharmaceutical biotech product development;Den Engelsman;Pharm Res,2011

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histidine as a versatile excipient in the protein-based biopharmaceutical formulations;International Journal of Pharmaceutics;2024-09

2. Suborgan Level Quantitation of Proteins in Tissues Delivered by Polymeric Nanocarriers;ACS Nano;2024-06-13

3. Parafilm® M and Strat-M® as skin simulants in in vitro permeation of dissolving microarray patches loaded with proteins;International Journal of Pharmaceutics;2024-04

4. Therapeutic proteins: developments, progress, challenges, and future perspectives;3 Biotech;2024-03-18

5. Comprehensive Perspective Towards the Management of Proteinopathies by Elucidating Protein Misfolding and Aggregation;CNS & Neurological Disorders - Drug Targets;2024-02